Precision BioSciences Net Worth
Precision BioSciences Net Worth Breakdown | DTIL |
Precision BioSciences Net Worth Analysis
Precision BioSciences' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Precision BioSciences' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Precision BioSciences' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Precision BioSciences' net worth analysis. One common approach is to calculate Precision BioSciences' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Precision BioSciences' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Precision BioSciences' net worth. This approach calculates the present value of Precision BioSciences' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Precision BioSciences' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Precision BioSciences' net worth. This involves comparing Precision BioSciences' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Precision BioSciences' net worth relative to its peers.
Enterprise Value |
|
To determine if Precision BioSciences is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Precision BioSciences' net worth research are outlined below:
| Precision BioSciences generated a negative expected return over the last 90 days | |
| Precision BioSciences has high historical volatility and very poor performance | |
| Precision BioSciences has high likelihood to experience some financial distress in the next 2 years | |
| Precision BioSciences currently holds about 184.14 M in cash with (58.45 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66. | |
| Latest headline from news.google.com: What analysts say about Precision BioSciences Inc. stock - Unprecedented profit potential - Autocar Professional |
Precision BioSciences uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Precision BioSciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Precision BioSciences' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 14th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Precision BioSciences' Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Precision BioSciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Precision BioSciences backward and forwards among themselves. Precision BioSciences' institutional investor refers to the entity that pools money to purchase Precision BioSciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Blackrock Inc | 2025-03-31 | 54.8 K | Dimensional Fund Advisors, Inc. | 2025-03-31 | 53.6 K | Northern Trust Corp | 2025-03-31 | 43 K | Moloney Securities Asset Management | 2025-03-31 | 42.9 K | Royal Bank Of Canada | 2025-03-31 | 40 K | Commonwealth Equity Services Inc | 2025-03-31 | 37.2 K | State Street Corp | 2025-03-31 | 22 K | Two Sigma Investments Llc | 2025-03-31 | 13.6 K | Morgan Stanley - Brokerage Accounts | 2025-03-31 | 12.3 K | Aquilo Capital Management, Llc | 2025-03-31 | 726.1 K | Tang Capital Management Llc | 2025-03-31 | 673.3 K |
Follow Precision BioSciences' market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 53.89 M.Market Cap |
|
Project Precision BioSciences' profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.05 | 0.06 | |
| Return On Capital Employed | (0.22) | (0.23) | |
| Return On Assets | 0.05 | 0.06 | |
| Return On Equity | 0.13 | 0.13 |
When accessing Precision BioSciences' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Precision BioSciences' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Precision BioSciences' profitability and make more informed investment decisions.
Evaluate Precision BioSciences' management efficiency
Precision BioSciences has return on total asset (ROA) of (0.1783) % which means that it has lost $0.1783 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5081) %, meaning that it created substantial loss on money invested by shareholders. Precision BioSciences' management efficiency ratios could be used to measure how well Precision BioSciences manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Precision BioSciences' Return On Tangible Assets are quite stable compared to the past year. Return On Assets is expected to rise to 0.06 this year, although the value of Return On Capital Employed will most likely fall to (0.23). At this time, Precision BioSciences' Return On Tangible Assets are quite stable compared to the past year. Intangibles To Total Assets is expected to rise to 0.01 this year, although the value of Non Current Assets Total will most likely fall to about 33.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 8.25 | 7.84 | |
| Tangible Book Value Per Share | 8.16 | 7.75 | |
| Enterprise Value Over EBITDA | (2.20) | (2.31) | |
| Price Book Value Ratio | 0.46 | 0.48 | |
| Enterprise Value Multiple | (2.20) | (2.31) | |
| Price Fair Value | 0.46 | 0.48 | |
| Enterprise Value | -29.8 M | -28.3 M |
The operational strategies employed by Precision BioSciences management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Enterprise Value Revenue 0.1254 | Revenue | Quarterly Revenue Growth (1.00) | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Precision BioSciences insiders, such as employees or executives, is commonly permitted as long as it does not rely on Precision BioSciences' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Precision BioSciences insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Precision BioSciences time-series forecasting models is one of many Precision BioSciences' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Precision BioSciences' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Precision BioSciences Earnings per Share Projection vs Actual
Precision BioSciences Corporate Management
| Maurissa Messier | Senior Communications | Profile | |
| Fayaz Khazi | Chief Systems | Profile | |
| Derek Jantz | Chief CoFounder | Profile | |
| Jefferson Smith | CoFounder Officer | Profile | |
| Cassie Gorsuch | Chief Officer | Profile | |
| Bruce Stevens | Vice Compliance | Profile | |
| John Kelly | Chief Officer | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.87) | Revenue Per Share | Quarterly Revenue Growth (1.00) | Return On Assets | Return On Equity |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.